This Thursday morning, the biopharmaceutical stock Pharming Group is gaining ground on the Paris Stock Exchange, building on a positive momentum that has been ongoing for several weeks. This rise is part of a slightly bullish Parisian market, with the CAC 40 up by 1.08%.
The stock opened at €1.62, up 6.65% from Wednesday's close of €1.52. The stock maintains robust short-term momentum, with a rebound of 2.99% over the last seven days. Over a broader perspective, the annual performance of the stock reaches 81.91%, significantly outperforming the CAC 40's twelve-month gain of 4.96%. The traded volumes represent about 2% of the capital, indicating moderate investor participation on this back-to-business day.
Technical Analysis
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
Technically, the stock is trading right at its upper Bollinger Band, set at €1.62, while it remains well above its 50-day moving average, which stands at €1.46. This setup highlights a well-controlled short-term bullish trend. The Relative Strength Index, at 58, is in a mid-range, signaling a present but not excessive buying dynamic. The monthly volatility of the stock, measured at 12.79%, remains comparable to industry standards.
Market Context
The favorable stock market context today, marked by the easing of international geopolitical tensions and relief in the Parisian market, has the stock resuming an upward trajectory after fluctuating earlier in the week, thus consolidating its quarterly performance with nearly a 39% increase.
SectorSanté · Vaccins et laboratoires de recherche›Industrie Pharmaceutique
Free · every morning · before 9am
Never miss a move on your stocks
The trend behind the prices · Euronext
✓ You're in! Check your spam folder.
An error occurred.
Les informations présentées dans cet article sont fournies à titre purement indicatif et ne constituent en aucun cas une recommandation d'investissement, une incitation à acheter ou vendre un actif financier, ni un conseil en placement. Le lecteur est invité à réaliser ses propres recherches avant toute décision.
Les investissements en bourse comportent des risques, notamment de perte en capital. La performance passée d'un actif ou d'un marché ne présage en rien de ses performances futures. Toute décision d'investissement doit être prise en tenant compte de votre situation financière personnelle, de vos objectifs et de votre tolérance au risque.
